2024 Commercial Success at Your Fingertips
As the industry’s tried and tested TPD series offering outstanding platforms for the industry, we are ecstatic to be offering cutting-edge service providers a gateway into the blossoming European TPD market.
With a landscape burgeoning with new start-ups and spinouts from academic research labs including the likes of Proxidrugs, Draupnir Bio, Booster Therapeutics, Yukin Therapeutics, Carrick Therapeutics, and Vico Therapeutics, drug developers are in need of early-stage discovery services including:
 |
Large scale, characterized ligase and ligand libraries for high throughput screening Hit Finding |
|
Bespoke antibody services to target specific assets and molecules |
|
Novel cell-based assays to measure degradation, ubiquitination, and ternary complex formation |
More established biopharma that are progressing their pipelines of degraders through the clinic such as Monte Rosa Therapeutics, Nurix Therapeutics, C4 Therapeutics, Kymera Therapeutics, Novartis, and Pfizer need proteomic capabilities, formulation solutions, and knowledge around ‘scale-up’ as the demand to produce more drugs, faster increases.
If you have relevant capabilities in this space and would like to align your brand with the targeted protein degradation community, please contact us to promote your company through our bespoke commercial packages.
Email sponsor@hansonwade.com to request more information.
Why Partner with the TPD Europe Summit?
RAISE YOUR BRAND AWARENESS
With the field growing at an astounding rate, the number of service providers is also increasing. Elevate your company’s footprint in Europe by partnering with the leading European TPD Forum
GENERATE COMMERCIAL OPPORTUNITIES
An increased number of European Biopharma represented on the faculty creates an unmissable opportunity to form connections and generate business with key decision makers in the European TPD landscape
UNCOVER THE NEXT MARKET TREND
Taking place in Q1 of 2024, this meeting provides an early opportunity to assess the early market trends and secure opportunities as leading companies look to equip their pipelines for success in the second half of the year
Our 2024 Audience
INTERESTED IN PARTNERING?
Contact: Jacob Roberts-Kendall, Senior Partnerships Director, Hanson Wade